Sign inGet started

EcoR1 Capital Fund Qualified, L.P.

Insider CIK 1598292 · ATYR 10% owner · KURA 10% owner · ASMB 10% owner · PANA Director, 10% owner · PANA Director, 10% owner · GNVC

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NUVB Nuvation Bio Inc. P Buy2023-09-212023-09-2253,000$1.36 $72.1K12,674,775SEC↗
NUVB Nuvation Bio Inc. P Buy2023-09-202023-09-22117,100$1.36 $159.3K12,621,775SEC↗
NUVB Nuvation Bio Inc. P Buy2023-09-192023-09-225,143,000$1.26 $6.48M12,504,675SEC↗
PANA Panacea Acquisition Corp. D To issuer2023-04-282023-05-02545,000— $00SEC↗
NUVB Nuvation Bio Inc. P Buy2023-02-212023-09-2153,000$1.36 $72.1K12,674,775SEC↗
NUVB Nuvation Bio Inc. P Buy2023-02-202023-09-21117,100$1.36 $159.3K12,621,775SEC↗
NUVB Nuvation Bio Inc. P Buy2023-02-192023-09-215,143,000$1.26 $6.48M12,504,675SEC↗
NUVB Nuvation Bio Inc. P Buy2021-11-242021-11-3021,758$7.69 $167.3K1,169,241SEC↗
NUVB Nuvation Bio Inc. P Buy2021-11-242021-11-30163,268$7.69 $1.26M7,361,675SEC↗
NUVB Nuvation Bio Inc. P Buy2021-07-312021-11-3056,598$8.64 $489.0K7,198,407SEC↗
NUVB Nuvation Bio Inc. S Sale2021-07-312021-11-3056,598$8.64 $489.0K1,147,483SEC↗
NUVB Nuvation Bio Inc. P Buy2021-04-132021-04-1327,534$10.27 $282.8K6,990,265SEC↗
NUVB Nuvation Bio Inc. P Buy2021-04-132021-04-133,966$10.27 $40.7K1,355,625SEC↗
NUVB Nuvation Bio Inc. P Buy2021-04-122021-04-13116,255$9.49 $1.10M6,962,731SEC↗
NUVB Nuvation Bio Inc. P Buy2021-04-122021-04-1316,745$9.49 $158.9K1,351,659SEC↗
PANA Panacea Acquisition Corp. P Buy2021-04-092021-04-13545,000$10.00 $5.45M545,000SEC↗
NUVB Nuvation Bio Inc. P Buy2021-04-092021-04-1337,770$10.03 $378.8K1,334,914SEC↗
NUVB Nuvation Bio Inc. P Buy2021-04-092021-04-13262,230$10.03 $2.63M6,846,476SEC↗
NUVB Nuvation Bio Inc. P Buy2021-03-312021-11-30151,544$10.45 $1.58M6,735,790SEC↗
NUVB Nuvation Bio Inc. S Sale2021-03-312021-11-30151,544$10.45 $1.58M1,145,600SEC↗
NUVB Nuvation Bio Inc. C Conversion deriv2021-02-102021-02-122,775,000— $00SEC↗
NUVB Nuvation Bio Inc. A Award deriv2021-02-102021-02-12702,000— $0702,000SEC↗
NUVB Nuvation Bio Inc. A Award deriv2021-02-102021-02-12131,333— $0131,333SEC↗
NUVB Nuvation Bio Inc. A Award deriv2021-02-102021-02-12130,000— $0130,000SEC↗
NUVB Nuvation Bio Inc. A Award2021-02-102021-02-122,365,511— $06,584,246SEC↗
NUVB Nuvation Bio Inc. A Award2021-02-102021-02-12387,265$10.00 $3.87M781,265SEC↗
NUVB Nuvation Bio Inc. A Award2021-02-102021-02-122,112,735$10.00 $21.13M4,218,735SEC↗
NUVB Nuvation Bio Inc. A Award2021-02-102021-02-122,200,627— $02,200,627SEC↗
NUVB Nuvation Bio Inc. A Award2021-02-102021-02-122,106,000— $02,106,000SEC↗
NUVB Nuvation Bio Inc. C Conversion2021-02-102021-02-122,775,000— $03,165,000SEC↗
NUVB Nuvation Bio Inc. A Award2021-02-102021-02-12515,879— $01,297,144SEC↗
NUVB Nuvation Bio Inc. A Award2021-02-102021-02-12394,000— $0394,000SEC↗
PANA Panacea Acquisition Corp P Buy2020-07-062020-07-06390,000$10.00 $3.90M390,000SEC↗
KURA Kura Oncology, Inc. P Buy2018-12-212019-01-1083,540$13.16 $1.10M4,408,097SEC↗
KURA Kura Oncology, Inc. P Buy2018-12-192019-01-1051,879$13.84 $718.0K4,324,557SEC↗
KURA Kura Oncology, Inc. P Buy2018-12-182019-01-1078,469$13.82 $1.08M4,272,678SEC↗
KURA Kura Oncology, Inc. S Sale2018-12-172019-01-1026,520$13.20 $350.1K4,194,209SEC↗
KURA Kura Oncology, Inc. P Buy2018-12-132018-12-1325,217$13.89 $350.3K4,220,729SEC↗
KURA Kura Oncology, Inc. P Buy2018-12-112018-12-1315,321$13.91 $213.1K4,195,512SEC↗
KURA Kura Oncology, Inc. P Buy2018-12-062018-12-0617,079$13.49 $230.4K4,180,919SEC↗
KURA Kura Oncology, Inc. P Buy2018-12-042018-12-0654,645$13.08 $714.8K4,163,112SEC↗
KURA Kura Oncology, Inc. P Buy2018-12-032018-12-0648,182$13.97 $673.1K4,108,467SEC↗
LIFE aTYR PHARMA INC S Sale2018-05-162018-05-162,733,231$0.81 $2.21M0SEC↗
LIFE aTYR PHARMA INC S Sale2018-05-152018-05-16121,294$1.43 $173.5K2,733,231SEC↗
LIFE aTYR PHARMA INC S Sale2018-05-142018-05-16354,791$1.72 $610.2K2,854,525SEC↗
ASMB ASSEMBLY BIOSCIENCES, INC. P Buy deriv2018-04-172018-04-18246$8.50 $2.1K1,213SEC↗
ASMB ASSEMBLY BIOSCIENCES, INC. P Buy deriv2018-04-132018-04-17967$7.47 $7.2K967SEC↗
ATYR aTYR PHARMA INC S Sale2017-11-132017-12-141,083$3.95 $4.3K3,209,316SEC↗
ATYR aTYR PHARMA INC S Sale2017-11-102017-12-145,860$4.00 $23.4K3,210,399SEC↗
ATYR aTYR PHARMA INC S Sale2017-11-092017-12-145,819$4.15 $24.1K3,216,259SEC↗
ATYR aTYR PHARMA INC S Sale2017-11-082017-12-141,070$4.30 $4.6K3,222,078SEC↗
ATYR aTYR PHARMA INC P Buy2017-11-012017-12-1424,728$4.80 $118.7K3,223,148SEC↗
ATYR aTYR PHARMA INC P Buy2017-10-012017-12-144,879$5.05 $24.6K3,198,420SEC↗
GNVC GENVEC INC P Buy2014-05-272014-05-274,662$2.39 $11.1K1,024,358SEC↗
GNVC GENVEC INC P Buy2014-05-272014-05-274,378$2.39 $10.5K962,055SEC↗
GNVC GENVEC INC P Buy2014-05-232014-05-272,372$2.19 $5.2K1,019,696SEC↗
GNVC GENVEC INC P Buy2014-05-232014-05-272,228$2.19 $4.9K957,677SEC↗
GNVC GENVEC INC P Buy2014-05-222014-05-275,085$2.13 $10.8K955,449SEC↗
GNVC GENVEC INC P Buy2014-05-222014-05-275,415$2.13 $11.5K1,017,324SEC↗
GNVC GENVEC INC P Buy2014-03-282014-03-2819,006$2.73 $51.9K785,366SEC↗
GNVC GENVEC INC P Buy2014-03-282014-03-2828,509$2.73 $77.8K1,176,907SEC↗
GNVC GENVEC INC P Buy2014-03-272014-03-2830,729$2.49 $76.5K1,148,398SEC↗
GNVC GENVEC INC P Buy2014-03-272014-03-2820,486$2.49 $51.0K766,360SEC↗
GNVC GENVEC INC P Buy2014-03-262014-03-289,417$2.31 $21.8K745,874SEC↗
GNVC GENVEC INC P Buy2014-03-262014-03-2814,126$2.31 $32.6K1,117,669SEC↗